Elephas harnesses latest advances in cancer biology, multimodal microscopy, and artificial intelligence to empower clinical decision-making.
Elephas has raised $40.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2025.
Elephas's investors include ARCH Venture Partners, Sands Capital Ventures, Venture Investors, Moore Strategic Ventures, Northpond Ventures.
Elephas is headquartered in Madison, United States.
Elephas harnesses latest advances in cancer biology, multimodal microscopy, and artificial intelligence to empower clinical decision-making.
Elephas is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Elephas — Funding & Investors." VCBacked, November 6, 2025, https://www.vcbacked.co/company/elephas. Accessed July 21, 2026.
VCBacked. (2025). Elephas — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/elephas
{{cite web |title=Elephas — Funding & Investors |url=https://www.vcbacked.co/company/elephas |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated